Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Anti-GQ1b antibody positivity
Very frequent (80-99%)HP:0034122
Areflexia
Very frequent (80-99%)HP:0001284
CPEO
Very frequent (80-99%)HP:0000544
Abnormal electromyography finding
Frequent (30-79%)HP:0003457
Ataxia
Frequent (30-79%)HP:0001251
Dilated pupil
Frequent (30-79%)HP:0011499
Double vision
Frequent (30-79%)HP:0000651
EEG: generalized slow activity
Frequent (30-79%)HP:0010845
Elevated csf protein
Frequent (30-79%)HP:0002922
Horizontal nystagmus
Frequent (30-79%)HP:0000666
Internal ophthalmoplegia
Frequent (30-79%)HP:0007942
Abnormality of ocular abduction
Occasional (5-29%)HP:0011347
Blurred vision
Occasional (5-29%)HP:0000622
Bulbar muscle weakness
Occasional (5-29%)HP:0001283
Cerebrospinal fluid pleocytosis
Occasional (5-29%)HP:0012229
Disturbances of consciousness
Occasional (5-29%)HP:0004372
Facial muscle weakness of muscles innervated by CN VII
Occasional (5-29%)HP:0010628
Headache
Occasional (5-29%)HP:0002315
Paresthesia
Occasional (5-29%)HP:0003401
Photophobia
Occasional (5-29%)HP:0000613
Pyrexia
Occasional (5-29%)HP:0001945
Quadriparesis
Occasional (5-29%)HP:0002273
Unequal pupil dilatation
Occasional (5-29%)HP:0009916
Deglutition disorder
Very rare (1-4%)HP:0002015
Eye drop
Very rare (1-4%)HP:0000508
Vomiting
Very rare (1-4%)HP:0002013
Quick Facts
- SNOMED CT
- 1767005
- UMLS CUI
- C0393799
- Fully Specified Name
- Fisher's syndrome (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 26
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.